Drug Enforcement Administration Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC, 35692-35693 [2019-15739]

Download as PDF 35692 Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices The company plans to import the listed controlled substance in bulk for manufacture of analytical reference material which, in its final form, is an exempted product. Dated: July 15, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–15738 Filed 7–23–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Application: AMRI Rensselaer, Inc. ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 23, 2019. Such persons may also file a written request for a hearing on the application on or before August 23, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia DATES: 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on May 7, 2019, AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New York 12144 applied to be registered as an importer of the following basic class of controlled substance: Controlled substance Drug code Poppy Straw Concentrate. 9670 Schedule II DEPARTMENT OF JUSTICE [Docket No. DEA–392] Drug Enforcement Administration Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 23, 2019. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: SUPPLEMENTARY INFORMATION: The company plans to import the listed controlled substance to manufacture a bulk controlled substance for distribution to its customers. Dated: July 15, 2019. John J. Martin, Assistant Administrator. In accordance with 21 CFR 1301.33(a), this is notice that on May 21, 2019, IsoSciences, LLC, 340 Mathers Road, Ambler, Pennsylvania 19002– 3420 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: [FR Doc. 2019–15737 Filed 7–23–19; 8:45 am] BILLING CODE 4410–09–P Drug code khammond on DSKBBV9HB2PROD with NOTICES Controlled substance Cathinone ................................................................................................................................................................................ Methcathinone ......................................................................................................................................................................... Lysergic acid diethylamide ...................................................................................................................................................... Marihuana ................................................................................................................................................................................ Tetrahydrocannabinols ............................................................................................................................................................ 3,4-Methylenedioxyamphetamine ............................................................................................................................................ 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................................... 3,4-Methylenedioxymethamphetamine .................................................................................................................................... 5-Methoxy-N-N-dimethyltryptamine ......................................................................................................................................... Alpha-methyltryptamine ........................................................................................................................................................... Bufotenine ................................................................................................................................................................................ Diethyltryptamine ..................................................................................................................................................................... Dimethyltryptamine .................................................................................................................................................................. Psilocybin ................................................................................................................................................................................. Psilocyn ................................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ..................................................................................................................................... Dihydromorphine ..................................................................................................................................................................... Heroin ...................................................................................................................................................................................... Nicocodeine ............................................................................................................................................................................. Nicomorphine ........................................................................................................................................................................... Normorphine ............................................................................................................................................................................ Thebacon ................................................................................................................................................................................. Normethadone ......................................................................................................................................................................... Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ......................................................................................... Para-Fluorofentanyl ................................................................................................................................................................. 3-Methylfentanyl ...................................................................................................................................................................... Alpha-methylfentanyl ............................................................................................................................................................... Acetyl-alpha-methylfentanyl ..................................................................................................................................................... N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ............................................................................................... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ....................................................................................... Butyryl Fentanyl ....................................................................................................................................................................... VerDate Sep<11>2014 16:53 Jul 23, 2019 Jkt 247001 PO 00000 Frm 00105 Fmt 4703 Sfmt 4703 E:\FR\FM\24JYN1.SGM 24JYN1 1235 1237 7315 7360 7370 7400 7404 7405 7431 7432 7433 7434 7435 7437 7438 7439 9145 9200 9309 9312 9313 9315 9635 9811 9812 9813 9814 9815 9816 9821 9822 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 35693 Federal Register / Vol. 84, No. 142 / Wednesday, July 24, 2019 / Notices Drug code Controlled substance 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ................................................. 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ................................................................................................. Beta-hydroxyfentanyl ............................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ................................................................................................................................................ Alpha-methylthiofentanyl ......................................................................................................................................................... 3-Methylthiofentanyl ................................................................................................................................................................. Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ..................................................................... Thiofentanyl ............................................................................................................................................................................. Beta-hydroxythiofentanyl ......................................................................................................................................................... N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .................................................................................. Amphetamine ........................................................................................................................................................................... Methamphetamine ................................................................................................................................................................... Codeine ................................................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................................ Oxycodone ............................................................................................................................................................................... Hydromorphone ....................................................................................................................................................................... Hydrocodone ........................................................................................................................................................................... Isomethadone .......................................................................................................................................................................... Methadone ............................................................................................................................................................................... Methadone intermediate .......................................................................................................................................................... Morphine .................................................................................................................................................................................. Thebaine .................................................................................................................................................................................. Levo-alphacetylmethadol ......................................................................................................................................................... Oxymorphone .......................................................................................................................................................................... Thiafentanil .............................................................................................................................................................................. Alfentanil .................................................................................................................................................................................. Sufentanil ................................................................................................................................................................................. Carfentanil ............................................................................................................................................................................... Fentanyl ................................................................................................................................................................................... The company plans to manufacture bulk controlled substances for use in analytical testing. In reference to drug codes 7360 (marihuana) and 7370 (THC), the company plans to bulk manufacture these drugs as synthetics. No other activities for these drug codes are authorized for this registration. Dated: July 11, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–15739 Filed 7–23–19; 8:45 am] BILLING CODE 4410–09–P LEGAL SERVICES CORPORATION Sunshine Act Meeting The Legal Services Corporation’s Board of Directors and its six committees will meet July 28–30, 2019. On Sunday, July 28, the first meeting will commence at 12:30 p.m., Eastern Daylight Time (EDT), with the meetings thereafter commencing promptly upon adjournment of the immediately preceding meeting. On Monday, July 29, the first meeting will commence at 9:30 a.m. (EDT), with the next meeting commencing promptly upon adjournment of the immediately preceding meeting. The closed session meeting of the Board of Directors will commence promptly upon adjournment of the open session of the Board of Directors meeting. khammond on DSKBBV9HB2PROD with NOTICES TIME AND DATE: VerDate Sep<11>2014 16:53 Jul 23, 2019 Jkt 247001 The Courtyard by Marriott Portland, Downtown Waterfront, 321 Commercial Street, Portland, Maine 04101. PLACE: Unless otherwise noted herein, the Board and all committee meetings will be open to public observation. Members of the public who are unable to attend in person but wish to listen to the public proceedings may do so by following the telephone call-in directions provided below. Call-in Directions for Open Sessions: • Call toll-free number: 1–866–451– 4981; • When prompted, enter the following numeric pass code: 5907707348. • Once connected to the call, your telephone line will be automatically ‘‘MUTED’’. • To participate in the meeting during public comment press #6 to ‘‘UNMUTE’’ your telephone line, once you have concluded your comments please press *6 to ‘‘MUTE’’ your line. Members of the public are asked to keep their telephones muted to eliminate background noises. To avoid disrupting the meeting, please refrain from placing the call on hold if doing so will trigger recorded music or other sound. From time to time, the presiding Chair may solicit comments from the public. STATUS: PO 00000 Frm 00106 Fmt 4703 Sfmt 4703 9824 9825 9830 9831 9832 9833 9834 9835 9836 9843 1100 1105 9050 9120 9143 9150 9193 9226 9250 9254 9300 9333 9648 9652 9729 9737 9740 9743 9801 Schedule I I I I I I I I I I II II II II II II II II II II II II II II II II II II II Meeting Schedule Sunday, July 28, 2019: Time: * 12:30 p.m. 1. Operations & Regulations Committee 2. Governance and Performance Review Committee 3. Communications Subcommittee Committee 4. Institutional Advancement Committee Monday, July 29, 2019: 9:30 a.m. 1. Audit Committee 2. Delivery of Legal Services Committee Tuesday, July 30, 2019: 8:00 a.m. 1. Finance Committee 2. Board of Directors Status of Meeting: Open, except as noted below. Board of Directors—Open, except that, upon a vote of the Board of Directors, a portion of the meeting may be closed to the public to hear briefings by management and LSC’s Inspector General, and to consider and act on the General Counsel’s report on potential and pending litigation involving LSC, and on a list of prospective funders.** * Please note that all times in this notice are in Eastern Daylight Time. ** Any portion of the closed session consisting solely of briefings does not fall within the Sunshine Act’s definition of the term ‘‘meeting’’ and, therefore, the requirements of the Sunshine Act do not apply to such portion of the closed session. 5 E:\FR\FM\24JYN1.SGM Continued 24JYN1

Agencies

[Federal Register Volume 84, Number 142 (Wednesday, July 24, 2019)]
[Notices]
[Pages 35692-35693]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15739]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[Docket No. DEA-392]


Drug Enforcement Administration Bulk Manufacturer of Controlled 
Substances Application: IsoSciences, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before September 23, 2019.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: 
    In accordance with 21 CFR 1301.33(a), this is notice that on May 
21, 2019, IsoSciences, LLC, 340 Mathers Road, Ambler, Pennsylvania 
19002-3420 applied to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance              Drug code      Schedule
------------------------------------------------------------------------
Cathinone...................................       1235  I
Methcathinone...............................       1237  I
Lysergic acid diethylamide..................       7315  I
Marihuana...................................       7360  I
Tetrahydrocannabinols.......................       7370  I
3,4-Methylenedioxyamphetamine...............       7400  I
3,4-Methylenedioxy-N-ethylamphetamine.......       7404  I
3,4-Methylenedioxymethamphetamine...........       7405  I
5-Methoxy-N-N-dimethyltryptamine............       7431  I
Alpha-methyltryptamine......................       7432  I
Bufotenine..................................       7433  I
Diethyltryptamine...........................       7434  I
Dimethyltryptamine..........................       7435  I
Psilocybin..................................       7437  I
Psilocyn....................................       7438  I
5-Methoxy-N,N-diisopropyltryptamine.........       7439  I
Dihydromorphine.............................       9145  I
Heroin......................................       9200  I
Nicocodeine.................................       9309  I
Nicomorphine................................       9312  I
Normorphine.................................       9313  I
Thebacon....................................       9315  I
Normethadone................................       9635  I
Acryl fentanyl (N-(1-phenethylpiperidin-4-         9811  I
 yl)-N-phenylacrylamide).
Para-Fluorofentanyl.........................       9812  I
3-Methylfentanyl............................       9813  I
Alpha-methylfentanyl........................       9814  I
Acetyl-alpha-methylfentanyl.................       9815  I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-      9816  I
 yl)propionamide.
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-        9821  I
 yl)-N-phenylacetamide).
Butyryl Fentanyl............................       9822  I

[[Page 35693]]

 
4-Fluoroisobutyryl fentanyl (N-(4-                 9824  I
 fluorophenyl)-N-(1-phenethylpiperidin-4-
 yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-         9825  I
 phenylacetamide.
Beta-hydroxyfentanyl........................       9830  I
Beta-hydroxy-3-methylfentanyl...............       9831  I
Alpha-methylthiofentanyl....................       9832  I
3-Methylthiofentanyl........................       9833  I
Furanyl fentanyl (N-(1-phenethylpiperidin-4-       9834  I
 yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl................................       9835  I
Beta-hydroxythiofentanyl....................       9836  I
N-(1-phenethylpiperidin-4-yl)-N-                   9843  I
 phenyltetrahydrofuran-2-carboxamide.
Amphetamine.................................       1100  II
Methamphetamine.............................       1105  II
Codeine.....................................       9050  II
Dihydrocodeine..............................       9120  II
Oxycodone...................................       9143  II
Hydromorphone...............................       9150  II
Hydrocodone.................................       9193  II
Isomethadone................................       9226  II
Methadone...................................       9250  II
Methadone intermediate......................       9254  II
Morphine....................................       9300  II
Thebaine....................................       9333  II
Levo-alphacetylmethadol.....................       9648  II
Oxymorphone.................................       9652  II
Thiafentanil................................       9729  II
Alfentanil..................................       9737  II
Sufentanil..................................       9740  II
Carfentanil.................................       9743  II
Fentanyl....................................       9801  II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for use 
in analytical testing. In reference to drug codes 7360 (marihuana) and 
7370 (THC), the company plans to bulk manufacture these drugs as 
synthetics. No other activities for these drug codes are authorized for 
this registration.

    Dated: July 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-15739 Filed 7-23-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.